未登录 A Phase 1b study of the OxPhos inhibitor ME-344 with bevacizumab in refractory metastatic colorectal cancer Boland, Patrick M.; Lenz, Heinz-Josef; Ciombor, Kristen K.; Florou, Vaia; Pishvaian, Michael J.; Cusnir, Michael; Cohen, Deirdre; Guo, Jessie Y.; Tang, Min; Rajagopalan, Prabhu; Wiley, Sandra E.; Ghalie, Richard G.; Hochster, Howard S. 分享 收藏
分享 收藏
The PI3Kδ inhibitor zandelisib on intermittent dosing in relapsed/refractory follicular lymphoma: Results from a global phase 2 study PI3Kδ 抑制剂zandelisib间歇给药治疗复发/难治性滤泡性淋巴瘤: 一项全球2期研究的结果 Zelenetz, Andrew D.; Jurczak, Wojciech; Ribrag, Vincent; Linton, Kim; Collins, Graham P.; Jimenez, Javier L.; Bishton, Mark; Dholaria, Bhagirathbhai; Mengarelli, Andrea; Phillips, Tycel J.; Sungala, Nagendraprasad; Musuraca, Gerardo; Sheehy, Oonagh; Van Den Neste, Eric; Odera, Mitsuhiko; Miao, Lu; Gold, Daniel P.; Ghalie, Richard G.; Zinzani, Pier L. 分享 收藏
Pracinostat plus azacitidine in older patients with newly diagnosed acute myeloid leukemia: results of a phase 2 study Garcia-Manero, Guillermo; Abaza, Yasmin; Takahashi, Koichi; Medeiros, Bruno C.; Arellano, Martha; Khaled, Samer K.; Patnaik, Mrinal; Odenike, Olatoyosi; Sayar, Hamid; Tummala, Mohan; Patel, Prapti; Maness-Harris, Lori; Stuart, Robert; Traer, Elie; Karamlou, Kasra; Yacoub, Abdulraheem; Ghalie, Richard; Giorgino, Ruben; Atallah, Ehab 分享 收藏
Phase 2, Randomized, Double-Blind Study of Pracinostat in Combination With Azacitidine in Patients With Untreated, Higher-Risk Myelodysplastic Syndromes Garcia-Manero, Guillermo; Montalban-Bravo, Guillermo; Berdeja, Jesus G.; Abaza, Yasmin; Jabbour, Elias; Essell, James; Lyons, Roger M.; Ravandi, Farhad; Maris, Michael; Heller, Brian; DeZern, Amy E.; Babu, Sunil; Wright, David; Anz, Bertrand; Boccia, Ralph; Komrokji, Rami S.; Kuriakose, Philip; Reeves, James; Sekeres, Mikkael A.; Kantarjian, Hagop M.; Ghalie, Richard; Roboz, Gail J. 分享 收藏
分享 收藏
Evidence of myeloid differentiation in non-M3 acute myeloid leukemia treated with the retinoid X receptor agonist bexarotene Tsai, Donald E.; Luger, Selina M.; Kemner, Allison; Swider, Cezary; Goradia, Ami; Tomczak, Ewa; DiPatri, Doris; Bagg, Adam; Nowell, Peter; Loren, Alison W.; Perl, Alexander; Schuster, Stephen; Thompson, James E.; Porter, David; Andreadis, Charlambos; Stadtmauer, Edward A.; Goldstein, Steven; Ghalie, Richard; Carroll, Martin 分享 收藏
A double-blind, placebo-controlled phase II study of the efficacy and safety of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease Reid, Marvin E.; El Beshlawy, Amal; Inati, Adlette; Kutlar, Abdullah; Abboud, Miguel R.; Haynes, Johnson, Jr.; Ward, Richard; Sharon, Bruce; Taher, Ali T.; Smith, Wally; Manwani, Deepa; Ghalie, Richard G. 分享 收藏
A dose-escalation phase IIa study of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease Kutlar, Abdullah; Reid, Marvin E.; Inati, Adlette; Taher, Ali T.; Abboud, Miguel R.; El-Beshlawy, Amal; Buchanan, George R.; Smith, Hedy; Ataga, Kenneth I.; Perrine, Susan P.; Ghalie, Richard G. 分享 收藏
A Phase 2 Trial of Immunotherapy With Mitumprotimut-T (Id-KLH) and GM-CSF Following Rituximab in Follicular B-cell Lymphoma Koc, Omer N.; Redfern, Charles; Wiernik, Peter H.; Rosenfelt, Fred; Winter, Jane N.; Carter, William D.; Gold, Dan P.; Stewart, Morgan E.; Ghalie, Richard G.; Bender, John F. 分享 收藏
分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
BLOOD.png)
.png){kind=icon}
分享.png){kind=icon}
收藏